Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
Parul TandonEugenia Y LeeCynthia MaxwellLara HitzLindsy AmbrosioLevinus DielemanBrendan HalloranKaren KroekerVivian Wai-Mei HuangPublished in: Digestive diseases and sciences (2020)
Fecal calprotectin may be a useful noninvasive marker to predict adverse pregnancy-related outcomes in patients with IBD.